Schrodinger, Inc. — Form D/A
Schrodinger, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2019-05-08. The offering totals $115.0M, of which $107.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-08
- Form: D/A
- Accession: 0001490978-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $115.0M
- Amount sold: $107.8M
- Remaining: $7.2M
- Investors: 13
- Date of first sale: 2018-11-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-325797
Issuer
- Name: Schrodinger, Inc.
- CIK: 0001490978
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 120 WEST 45TH STREET, NEW YORK, NY, 10036
- Phone: 503-299-1150
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Ramy Farid | Director | New York, NY |
| Richard Friesner | Director | New York, NY |
| Rosana Kapeller-Liebermann | Director | New York, NY |
| Michael Lynton | Director | New York, NY |
| Timothy Wright | Director | Boston, MA |
| CONY D'CRUZ | Executive Officer | BOSTON, MA |
| Ramy Farid | Executive Officer | New York, NY |
| Joel Lebowitz | Executive Officer | New York, NY |
| Yvonne Tran | Executive Officer | New York, NY |
| Murco Ringnalda | Executive Officer | New York, NY |
| Charles Ardai | Director | New York, NY |
| Joshua Distler | Director | New York, NY |
| Wayne Guida | Director | New York, NY |
| Louis Salkind | Director | New York, NY |
Other filings by this issuer (4)
More